Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results

被引：0
|
作者：
Atul A. Deodhar
Philip J. Mease
Proton Rahman
Victoria Navarro-Compán
Vibeke Strand
Theresa Hunter
Rebecca Bolce
Luis Leon
Steve Lauzon
Helena Marzo-Ortega
机构：
[1] Oregon Health & Science University,Division of Arthritis and Rheumatic Diseases
[2] Swedish Medical Center/ Providence St. Joseph Health and University of Washington,Department of Rheumatology
[3] Memorial University of Newfoundland,Division of Immunology/Rheumatology
[4] Hospital Universitario La Paz,National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust and LIRMM
[5] IdiPAZ,undefined
[6] Stanford University School of Medicine,undefined
[7] Eli Lilly and Company,undefined
[8] University of Leeds,undefined
来源：
BMC Rheumatology | / 5卷
关键词：
ASAS; PROs; Spinal pain; Stiffness; Fatigue; Radiographic axial spondyloarthritis; Ixekizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
    Maksymowych, Walter P.
    Thom, Howard
    Morup, Michael F.
    Taieb, Vanessa
    Willems, Damon
    Lyris, Nikos
    Gaffney, Karl
    [J]. RHEUMATOLOGY AND THERAPY, 2024, 11 (04) : 1023 - 1041
  • [22] RESPONSE TO IXEKIZUMAB BY C-REACTIVE PROTEIN LEVEL IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE COAST-V (BIOLOGICAL-NAIVE) AND COAST-W (TNF-A INHIBITOR-EXPERIENCED) TRIALS AT 52 WEEKS
    Chaudhury, Koyel
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    Robinson, Philip
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 34 - 35
  • [23] Ixekizumab: 52-Week Efficacy and Safety in Radiographic Axial Spondyloarthritis Patients with Prior Inadequate Response/Intolerance to Tumor Necrosis Factor Inhibitors
    Dougados, Maxime
    Sieper, Joachim
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Maksymowych, Walter P.
    Ermann, Joerg
    Li, Xiaoqi
    Gallo, Gaia
    Carlier, Hilde
    Gensler, Lianne
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] Response to Ixekizumab by C-reactive Protein Level in Patients With Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naive) and COAST-W (TNF- alpha Inhibitor-Experienced) Trials at 52 Weeks
    Reveille, John
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1121 - 1121
  • [25] Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies
    Mease, Philip J.
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina Nighat
    Marzo-Ortega, Helena
    Rudwaleit, Martin
    de la Loge, Christine
    Fleurinck, Carmen
    Massow, Ute
    Taieb, Vanessa
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 996 - 1000
  • [26] Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
    Helena Marzo-Ortega
    Philip J. Mease
    Proton Rahman
    Victoria Navarro-Compán
    Vibeke Strand
    Maxime Dougados
    Bernard Combe
    James Cheng-Chung Wei
    Xenofon Baraliakos
    Theresa Hunter
    David Sandoval
    Xiaoqi Li
    Baojin Zhu
    Louis Bessette
    Atul Deodhar
    [J]. Rheumatology and Therapy, 2020, 7 : 759 - 774
  • [27] IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE COAST-V AND COAST-W TRIALS AT 52 WEEKS
    Marzo-Ortega, H.
    Mease, P. J.
    Rahman, P.
    Navarro-Compan, V.
    Strand, V.
    Dougados, M.
    Combe, B.
    Wei, J. C. C.
    Baraliakos, X.
    Hunter, T.
    Sandoval, D.
    Li, X.
    Zhu, B.
    Bessette, L.
    Deodhar, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 429 - 430
  • [28] Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) (vol 79, pg 176, 2020)
    Dougados, M.
    Wei, J. C-C
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06)
  • [29] Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
    Marzo-Ortega, Helena
    Mease, Philip J.
    Rahman, Proton
    Navarro-Compan, Victoria
    Strand, Vibeke
    Dougados, Maxime
    Combe, Bernard
    Wei, James Cheng-Chung
    Baraliakos, Xenofon
    Hunter, Theresa
    Sandoval, David
    Li, Xiaoqi
    Zhu, Baojin
    Bessette, Louis
    Deodhar, Atul
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 759 - 774
  • [30] Ixekizumab Improves Self-reported Overall Functioning and Health as Measured by the Assessment of SpondyloArthritis International Society Health Index in Patients with Active Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Randomized Trials
    Kiltz, Uta
    van der Heijde, Desiree
    Boonen, Annelies
    Gensler, Lianne
    Hunter, Theresa
    Zhao, Fangyi
    Zhu, Baojin
    Bolce, Rebecca
    Carlier, Hilde
    Braun, Juergen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345